Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-08-08 Sale |
2022-08-10 4:22 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
274,568 | $38.11 | $10,464,363 | 5,753,739 (Indirect) |
View |
2021-10-20 Sale |
2021-10-20 7:14 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
10,083 | $58.67 | $591,527 | 779,218 (Direct) |
View |
2021-10-18 Sale |
2021-10-19 7:27 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
52,417 | $58.65 | $3,074,378 | 769,135 (Direct) |
View |
2021-10-13 Sale |
2021-10-13 8:24 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $55.97 | $559,675 | 251,807 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,551 | $28.47 | 193,076 (Direct) |
View |
2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
3,103 | $28.47 | 49,584 (Direct) |
View |
2022-07-14 Option Award |
2022-07-15 06:07 am |
N/A 2032-07-14 |
SpringWorks Therapeutics Inc. | SWTX | ALBAN CARLOS Director |
40,218 | $0 | 40,218 (Direct) |
View |
2022-06-30 Option Award |
2022-07-05 5:30 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
6,092 | $0 | 194,627 (Direct) |
View |
2022-06-01 Tax Withholding |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
2,672 | $19.61 | 52,687 (Direct) |
View |
2022-06-30 Option Award |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
12,185 | $0 | 52,687 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 6:23 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director |
20,136 | $0 | 4,852,549 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:44 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
20,136 | $0 | 6,333,277 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:43 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
20,136 | $0 | 312,519 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:41 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director |
20,136 | $0 | 21,242 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:40 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director |
20,136 | $0 | 21,242 (Direct) |
View |
2022-05-19 Option Award |
2022-05-20 5:39 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director |
20,136 | $0 | 21,242 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
414 | $56.06 | 8,334 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
631 | $56.06 | 21,667 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
966 | $56.06 | 19,096 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr Chief Financial Officer |
1,307 | $56.06 | 27,502 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,181 | $56.06 | 188,535 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
1,852 | $56.06 | 325,813 (Direct) |
View |
2022-01-07 Tax Withholding(A) |
2022-01-14 4:57 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
3,996 | $56.06 | 853,592 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
1,323 | $56.06 | 18,739 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
842 | $56.06 | 21,456 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr Chief Financial Officer |
1,846 | $56.06 | 26,963 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
567 | $56.06 | 8,181 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,772 | $56.06 | 187,944 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
5,893 | $56.06 | 851,695 (Direct) |
View |
2022-01-07 Tax Withholding |
2022-01-11 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
2,531 | $56.06 | 325,134 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:31 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
322,628 | $0 | 1,101,846 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:27 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
107,544 | $0 | 409,085 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:26 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr Chief Financial Officer |
77,431 | $0 | 87,431 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:25 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
91,412 | $0 | 258,923 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:25 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
53,772 | $0 | 60,772 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:24 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
53,772 | $0 | 63,008 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
64,526 | $0 | 92,026 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
53,772 | $0 | 66,272 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:22 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
23,661 | $0 | 26,661 (Direct) |
View |
2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 251,807 (Direct) |
View |
2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 251,807 (Direct) |
View |
2021-09-08 Exercise |
2021-09-09 5:15 pm |
N/A 2030-08-03 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
2,320 | $0 | 81,916 (Direct) |
View |
2021-09-08 Exercise |
2021-09-09 5:15 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
2,320 | $43.1 | 81,916 (Direct) |
View |